Discontinued — last reported Q4 '20
Dow Business Sale Proceeds remained flat by 0.0% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.3%, from $3.00M to $4.00M. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows an upward trend with a 19.6% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $5.00M | $53.00M | $4.00M | $1.00M | $11.00M | $16.00M | $57.00M | $2.00M | $7.00M | $29.00M | $2.00M | $6.00M | $28.00M | $198.00M | $3.00M | $128.00M | $4.00M | $4.00M | $4.00M |
| QoQ Change | — | +400.0% | +960.0% | -92.5% | -75.0% | >999% | +45.5% | +256.3% | -96.5% | +250.0% | +314.3% | -93.1% | +200.0% | +366.7% | +607.1% | -98.5% | >999% | -96.9% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +120.0% | -69.8% | >999% | +100.0% | -36.4% | +81.3% | -96.5% | +200.0% | +300.0% | +582.8% | +50.0% | >999% | -85.7% | -98.0% | +33.3% |
| Segment | Q2 '25 | Q3 '25 |
|---|---|---|
| Corporate Segment | — | $121.00M |
| Industrial Intermediates & Infrastructure | $121.00M | — |
| Total | $128.00M | $4.00M |
Packaging & Specialty Plastics is derived from annual filings.
Corporate Segment, Industrial Intermediates & Infrastructure were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.